Silence Therapeutics To Be Acquired By Merck KGaA

By Reuters News

- Silence Therapeutics PLC SLNCF.PK:

  • ENTERS INTO AGREEMENT TO BE ACQUIRED BY MERCK KGAA, DARMSTADT, GERMANY

  • ALL-CASH DEAL VALUES SILENCE THERAPEUTICS AT ABOUT $1.30 BILLION

  • ENTERS AGREEMENT TO BE BOUGHT BY MERCK KGAA, DARMSTADT, GERMANY

  • PRICE OF $20 PER ADS IN CASH

  • DEAL ENTERPRISE VALUE OF $1.10 BILLION

  • SHAREHOLDERS TO RECEIVE $20 PER ADS OR $6.67 PER ORDINARY SHARE

  • SECURITYHOLDERS WITH 14% VOTING POWER ENTER VOTING AND SUPPORT AGREEMENT

Further company coverage: SLNCF.PK

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk